A publication for friends and colleagues of
Jefferson’s Department of Surgery
Winter 2022
Volume 16, Number 2

SurgicalSolutions
HIPEC Program Combines Surgery
and Heated Chemotherapy to Treat
Advanced Abdominal Cancers
“That’s the range that scientific research has
shown is optimal for chemotherapeutic drugs
to penetrate and kill any remaining cancer cells,”
says Dr. Bowne. “This regional perfusion enables
us to deliver a much higher concentration of
chemotherapy than a patient could tolerate in
the bloodstream.”
HIPEC is an effective treatment option for
selected patients with appendiceal/PMP cancer
as well as other abdominal conditions, such as
peritoneal mesothelioma and cancer of the colon,
ovaries and stomach.

Over 6 years ago, Mary Johnson was referred to Dr. Wilbur Bowne with a rare and concerning diagnosis—pseudomyxoma peritonei (PMP).

Six years ago, when Mary E. Johnson began
experiencing a change in bowel habits, she didn’t
hesitate to schedule an appointment with her
primary care physician, Katie M. Dougherty, DO.
Now 73, Johnson recalls hoping Dr. Dougherty
would prescribe medication and send her home.
Instead, the physician ordered a battery of tests
that led to a serious and rare (approximately one
in a million) diagnosis: pseudomyxoma peritonei
(PMP), a slow-growing cancer of the appendix.
In 2019, Kathleen Neider, now 66, was suffering
from recurring pains in her abdomen. After
months of pushing through the pain, Neider’s
sister, a nurse, insisted she be seen at the
hospital. After testing by a gastroenterologist,
she, too, was diagnosed with cancer of the
appendix. Neider was initially treated with bowel
surgery followed by a course of chemotherapy.
After a year of remission, follow-up scans
showed cancer recurrence on her ovaries
and near the site of the earlier resection.
Historically, patients with PMP and other
advanced abdominal cancers faced a poor

In this issue

prognosis, with treatment largely focused on
alleviating symptoms rather than preventing
disease progression and increasing survival rates.
Johnson and Neider were able to take advantage
of an effective treatment option: cytoreductive
surgery with hyperthermic intraperitoneal
chemotherapy (HIPEC), a newer treatment
available at only a few institutions in the
Delaware Valley.
Both women underwent the procedure with
surgical oncologist Wilbur B. Bowne, MD, who
has been performing this treatment for over a
decade and established the Jefferson HIPEC
Program in January 2020. As Dr. Bowne explains,
HIPEC surgery is a two-part treatment. The first
step is cytoreductive surgery to remove all visible
tumors in the abdominal cavity. The second part
involves administering high doses of heated
chemotherapy to eliminate remaining
microscopic cancer cells. The solution is
circulated throughout the patient’s abdomen
and pelvis for at least 90 minutes at a
temperature of 41 to 43 degrees Celsius (106 to
109 degrees Fahrenheit).
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Dr. Bowne notes that Jefferson’s HIPEC Program
relies on important partnerships and
multidisciplinary collaboration with a range of
specialists, including gynecologic oncology
surgeons, anesthesiologists, surgical oncologists,
urologists, medical oncologists, operating room
staff, and nurse practitioners. Madison Halder, RN,
and clinical coordinator Angela Owens, in
particular, are essential team members who help
patients navigate their pre- and post-op
experience.
HIPEC is a lengthy and complex procedure and
not suitable for every patient (Johnson’s and
Neider’s HIPEC procedures lasted 13 and 10
hours, respectively). Dr. Bowne explains that a
patient typically needs to demonstrate a favorable
treatment response to traditional chemotherapy,
along with sufficient stamina to undergo and
recover from the procedure.
Two months after HIPEC treatment, Neider is still
navigating her recovery and praises Dr. Bowne
and the team for her care.
“Dr. Bowne and his staff have been amazing.
I have called him, and he always takes my calls
and answers my questions. We always decide
together what we’re going to do,” she says.
For Johnson, it’s been over six years since she
met Dr. Bowne and underwent her HIPEC
procedure. She remains “ecstatic” about her
outcome, adding that she takes minimal
medication and is “feeling good.”
“I thank God that the scientific and medical brains
came together to save my life,” Johnson says.
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